Page 454 - Documents for the COPC of BS Nursing Program
P. 454

CAGAYAN STATE UNIVERSITY                                                                                                             13
                                NCM 112

                                                        iii.   Lymphoma
                                                              (Hodgkin’s,                                   1.  Pathophysiology of
                                                              Non-                                             Megaloblastic Anemia:
                                                              Hodgkin’s)                                           o  Explain the
                                            3.  Bleeding Disorders                                                    pathophysiologica
                                                   a.  Thrombocytopenia                                               l mechanism of
                                                   b.  Autoimmune                                                     megaloblastic
                                                      Idiopathic                                                      anemia. How
                                                      Thrombocytopenic                                                does the
                                                      Purpura (AITP)                                                  deficiency of
                                                   c.  Hemophilia                                                     vitamin B12
                                                   d.  Disseminated                                                   contribute to the
                                                      Intravascular                                                   development of
                                                      Coagulation                                                     the clinical
                                                   e.  Von Willebrand                                                 features seen in
                                                      Disease                                                         Ms. Anita?
                                            4.  Other Lymphatic Disorders                                   2.  Dietary Considerations
                                                   a.  Lymphangitis and                                        and Management:
                                                      Lymphadenitis                                                o  Considering Ms.
                                                   b.  Lymphedema                                                     Anita’s dietary
                                    E.  Implementation of Common                                                      habits, what
                                        Hematolymphatic Modalities                                                    dietary advice
                                            1.  Plasmapheresis                                                        would you offer
                                            2.  Review of Pharmacotherapy                                             her? Discuss the
                                                                                                                      importance of
                                                                                                                      vitamin B12 in the
                                                                                                                      diet and potential
                                                                                                                      sources,
                                                                                                                      especially for
                                                                                                                      vegetarians.
                                                                                                            3.  Additional
                                                                                                               Assessments and
                                                                                                               Monitoring:
                                                                                                                   o  What additional
                                                                                                                      assessments

                           F-ODI-2056
                                                                                                                                     Revision No. 07 January 31, 2024
   449   450   451   452   453   454   455   456   457   458   459